• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管外膜下剥离技术在累及动脉的胰腺癌切除术中的应用:一项回顾性队列研究。

Sub-adventitial divestment technique for resecting artery-involved pancreatic cancer: a retrospective cohort study.

机构信息

Pancreas Centre, The First Affiliated Hospital Nanjing Medical University, 300 Guangzhou Road, Nanjing, Jiangsu Province, People's Republic of China.

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Im Neuenheimer Feld 110, 69120, Heidelberg, Germany.

出版信息

Langenbecks Arch Surg. 2021 May;406(3):691-701. doi: 10.1007/s00423-021-02080-5. Epub 2021 Jan 28.

DOI:10.1007/s00423-021-02080-5
PMID:33507403
Abstract

PURPOSE

To introduce sub-adventitial divestment technique (SDT), a procedure to remove the tumor while preserving the artery during curative pancreatectomy. Peri-operative safety profile was also evaluated.

METHODS

In a single center consecutive series of pancreatectomy for pancreatic cancer, the outcome of patients who had pancreatectomy with SDT was compared to standard pancreatic surgery.

RESULTS

From June 2014 to June 2016, 72 patients had pancreatectomy with SDT and 235 had standard surgery. Tumor stage was T4 in all 72 (100%) tumors removed using SDT compared to four (2%) with standard pancreatectomy (p < 0.001). All 72 (100%) tumors in the SDT group were stage III compared to 24 (10%) in the standard surgery group (p < 0.001). Both groups had a high proportion of poorly differentiated tumors (52 (72%) and 163 (69%) respectively) and perineural tumor invasion (62 (86%) and 186 (79%) respectively). R1 (< 1 mm) was found in 24 (86%) of 28 tumors in the SDT group, and in 72 (60%) out of 120 standard pancreatectomy tumors (p = 0.01). Complications occurred in 29 (40%) of the SDT group and in 88 (37%) of the standard group. The in-hospital mortality was four (6%) in the SDT group and one (0.4%) in the standard group (p = 0.01), with a 90-day mortality of 5 (8%)/60 and 6 (3%)/209 (p = 0.07) respectively.

CONCLUSIONS

The sub-adventitial divestment technique appeared to be an effective surgical technique to remove the tumor while preserving the artery. This approach warrants further validation in prospective studies.

摘要

目的

介绍亚外膜剥离技术(SDT),一种在根治性胰腺切除术中切除肿瘤同时保留动脉的手术方法。同时评估其围手术期安全性。

方法

在一项连续的单中心胰腺切除术系列研究中,将 SDT 组与标准胰腺手术组的患者手术结果进行比较。

结果

2014 年 6 月至 2016 年 6 月,72 例患者接受了 SDT 胰腺切除术,235 例患者接受了标准手术。使用 SDT 切除的所有 72 例(100%)肿瘤均为 T4 期,而标准胰腺切除术组仅 4 例(2%)为 T4 期(p < 0.001)。SDT 组所有 72 例(100%)肿瘤均为 III 期,而标准手术组为 24 例(10%)(p < 0.001)。两组均有较高比例的低分化肿瘤(分别为 52 例[72%]和 163 例[69%])和神经周围肿瘤侵犯(分别为 62 例[86%]和 186 例[79%])。SDT 组 28 例肿瘤中有 24 例(86%)为 R1(< 1mm),标准胰腺切除术组 120 例中有 72 例(60%)为 R1(p = 0.01)。SDT 组发生并发症 29 例(40%),标准手术组发生并发症 88 例(37%)。SDT 组住院死亡率为 4 例(6%),标准手术组为 1 例(0.4%)(p = 0.01),90 天死亡率分别为 5 例(8%)/60 例和 6 例(3%)/209 例(p = 0.07)。

结论

亚外膜剥离技术似乎是一种有效的手术方法,可以在保留动脉的同时切除肿瘤。这一方法值得在前瞻性研究中进一步验证。

相似文献

1
Sub-adventitial divestment technique for resecting artery-involved pancreatic cancer: a retrospective cohort study.血管外膜下剥离技术在累及动脉的胰腺癌切除术中的应用:一项回顾性队列研究。
Langenbecks Arch Surg. 2021 May;406(3):691-701. doi: 10.1007/s00423-021-02080-5. Epub 2021 Jan 28.
2
Periarterial and Sub-adventitial Divestment Along with Triangle Operation and RAMPS for Pancreatic Body Cancer.沿胰腺体癌动脉外膜和外膜下剥离联合三角形手术和 RAMPS
Ann Surg Oncol. 2024 Jul;31(7):4688-4690. doi: 10.1245/s10434-024-15303-y. Epub 2024 May 7.
3
[Comparison of distal pancreatectomy with celiac axis resection and sub-adventitial divestment technique for locally advanced or borderline resectable pancreatic body cancer].[远端胰腺切除术联合腹腔干切除及外膜下剥离技术治疗局部进展期或交界可切除胰体癌的比较]
Zhonghua Wai Ke Za Zhi. 2022 May 1;60(5):441-448. doi: 10.3760/cma.j.cn112139-20210824-00390.
4
A histopathological study of artery wall involvement in pancreatic cancer surgery.胰腺癌手术中动脉壁受累的组织病理学研究。
Langenbecks Arch Surg. 2022 Dec;407(8):3501-3511. doi: 10.1007/s00423-022-02689-0. Epub 2022 Nov 7.
5
Locally advanced pancreatic duct adenocarcinoma: pancreatectomy with planned arterial resection based on axial arterial encasement.局部进展期胰腺导管腺癌:基于轴向动脉包绕情况行计划性动脉切除的胰腺切除术
Langenbecks Arch Surg. 2016 Dec;401(8):1131-1142. doi: 10.1007/s00423-016-1488-y. Epub 2016 Jul 30.
6
Arterial Divestment and Resection in Post-neoadjuvant Pancreatic Adenocarcinoma.新辅助治疗后胰腺腺癌的动脉剥离与切除
Cureus. 2021 Dec 8;13(12):e20275. doi: 10.7759/cureus.20275. eCollection 2021 Dec.
7
Technical options in surgery for artery-involving pancreatic cancer: Invasion depth matters.累及动脉的胰腺癌手术的技术选择:侵犯深度至关重要。
Surg Open Sci. 2023 Mar 3;12:55-61. doi: 10.1016/j.sopen.2023.03.001. eCollection 2023 Mar.
8
[Anatomy of the head of the pancreas and various limited resection procedures for intraductal papillary-mucinous tumors of the pancreas].[胰腺头部的解剖结构及胰腺导管内乳头状黏液性肿瘤的各种局限性切除手术]
Nihon Geka Gakkai Zasshi. 2003 Jun;104(6):460-70.
9
Should all distal pancreatectomies be performed laparoscopically?所有远端胰腺切除术都应该通过腹腔镜进行吗?
Adv Surg. 2009;43:283-300. doi: 10.1016/j.yasu.2009.02.013.
10
Laparoscopic versus open distal pancreatectomy for benign or premalignant pancreatic neoplasms: a two-center comparative study.腹腔镜与开放手术治疗良性或癌前胰腺肿瘤的远端胰腺切除术:一项双中心比较研究。
J Zhejiang Univ Sci B. 2015 Jul;16(7):573-9. doi: 10.1631/jzus.B1400257.

引用本文的文献

1
Standardization of surgical procedure for initially unresectable locally advanced pancreatic head cancer.初始不可切除的局部晚期胰头癌手术程序的标准化
Langenbecks Arch Surg. 2025 Jul 17;410(1):226. doi: 10.1007/s00423-025-03745-1.
2
Phenotypic heterogeneity and tumor immune microenvironment directed therapeutic strategies in pancreatic ductal adenocarcinoma.胰腺导管腺癌的表型异质性与肿瘤免疫微环境导向治疗策略
Front Immunol. 2025 Mar 31;16:1573522. doi: 10.3389/fimmu.2025.1573522. eCollection 2025.
3
Impact of Surgical Resection After Induction Gemcitabine Plus S-1-Based Chemoradiotherapy in Patients with Locally Advanced Pancreatic Ductal Adenocarcinoma: A Focus on UR-LA Cases.

本文引用的文献

1
En Bloc Celiac Axis Resection for Pancreatic Cancer: Classification of Anatomical Variants Based on Tumor Extent.整块腹腔干切除术治疗胰腺癌:基于肿瘤范围的解剖变异分类。
J Am Coll Surg. 2020 Jul;231(1):8-29. doi: 10.1016/j.jamcollsurg.2020.05.005. Epub 2020 May 15.
2
Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial.胰腺导管腺癌切除术后复发模式:ESPAC-4 随机辅助化疗试验的二次分析。
JAMA Surg. 2019 Nov 1;154(11):1038-1048. doi: 10.1001/jamasurg.2019.3337.
3
Novel implications of combined arterial resection for locally advanced pancreatic cancer in the era of newer chemo-regimens.
吉西他滨联合基于S-1的诱导放化疗后手术切除对局部晚期胰腺导管腺癌患者的影响:聚焦于UR-LA病例
Cancers (Basel). 2025 Mar 20;17(6):1048. doi: 10.3390/cancers17061048.
4
Nationwide implementation of the international multidisciplinary best-practice for locally advanced pancreatic cancer (PREOPANC-4): study protocol.局部晚期胰腺癌国际多学科最佳实践(PREOPANC-4)的全国性实施:研究方案。
BMC Cancer. 2025 Feb 19;25(1):299. doi: 10.1186/s12885-025-13554-w.
5
Periarterial Divestment and Triangle Clearance in Pancreatic Cancer: A Video Vignette.胰腺癌的动脉周围剥离术和三角清扫术:视频病例
Ann Surg Oncol. 2025 Feb;32(2):1331-1333. doi: 10.1245/s10434-024-16542-9. Epub 2024 Nov 27.
6
Evolution and improved outcomes in the era of multimodality treatment for extended pancreatectomy.扩大胰切除术多模式治疗时代的进展与改善的治疗效果
BJS Open. 2024 Jul 2;8(4). doi: 10.1093/bjsopen/zrae065.
7
ASO Author Reflections: Radical Resection for Locally Advanced Pancreatic Cancer: Arterial Resection Versus Divestment?ASO作者反思:局部晚期胰腺癌的根治性切除术:动脉切除还是血管剥离?
Ann Surg Oncol. 2024 Jul;31(7):4704-4705. doi: 10.1245/s10434-024-15403-9. Epub 2024 May 9.
8
Periarterial and Sub-adventitial Divestment Along with Triangle Operation and RAMPS for Pancreatic Body Cancer.沿胰腺体癌动脉外膜和外膜下剥离联合三角形手术和 RAMPS
Ann Surg Oncol. 2024 Jul;31(7):4688-4690. doi: 10.1245/s10434-024-15303-y. Epub 2024 May 7.
9
Multimodal Approaches to Patient Selection for Pancreas Cancer Surgery.多模态方法在胰腺癌手术患者选择中的应用。
Curr Oncol. 2024 Apr 15;31(4):2260-2273. doi: 10.3390/curroncol31040167.
10
REDISCOVER International Guidelines on the Perioperative Care of Surgical Patients With Borderline-resectable and Locally Advanced Pancreatic Cancer.重新发现关于伴可切除和局部进展期胰腺癌手术患者围手术期护理的国际指南。
Ann Surg. 2024 Jul 1;280(1):56-65. doi: 10.1097/SLA.0000000000006248. Epub 2024 Feb 26.
新辅助化疗时代联合动脉切除治疗局部进展期胰腺癌的新意义。
Eur J Surg Oncol. 2019 Oct;45(10):1895-1900. doi: 10.1016/j.ejso.2019.05.019. Epub 2019 May 22.
4
Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Phase 2 Clinical Trial.FOLFIRINOX 新辅助治疗联合氯沙坦联合放化疗治疗局部晚期胰腺癌:一项 2 期临床试验。
JAMA Oncol. 2019 Jul 1;5(7):1020-1027. doi: 10.1001/jamaoncol.2019.0892.
5
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.FOLFIRINOX 或吉西他滨作为胰腺癌的辅助治疗。
N Engl J Med. 2018 Dec 20;379(25):2395-2406. doi: 10.1056/NEJMoa1809775.
6
Indications and Perioperative Outcomes for Pancreatectomy with Arterial Resection.动脉切除的胰腺切除术的适应证和围手术期结果。
J Am Coll Surg. 2018 Aug;227(2):255-269. doi: 10.1016/j.jamcollsurg.2018.05.001. Epub 2018 May 9.
7
The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma.阳性切缘对胰导管腺癌切除和辅助化疗后生存及复发的影响。
Ann Surg. 2019 Mar;269(3):520-529. doi: 10.1097/SLA.0000000000002557.
8
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial.比较吉西他滨和卡培他滨辅助治疗与吉西他滨单药治疗可切除胰腺癌患者的效果(ESPAC-4):一项多中心、开放标签、随机、3 期临床试验。
Lancet. 2017 Mar 11;389(10073):1011-1024. doi: 10.1016/S0140-6736(16)32409-6. Epub 2017 Jan 25.
9
The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After.国际研究小组(ISGPS)术后胰瘘定义与分级的2016年更新:11年后
Surgery. 2017 Mar;161(3):584-591. doi: 10.1016/j.surg.2016.11.014. Epub 2016 Dec 28.
10
Outcomes after extended pancreatectomy in patients with borderline resectable and locally advanced pancreatic cancer.边缘可切除和局部进展期胰腺癌患者行扩大胰切除术的结果。
Br J Surg. 2016 Nov;103(12):1683-1694. doi: 10.1002/bjs.10221. Epub 2016 Sep 30.